Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 90 institutions that hold shares in the stock, with a total of 53 Million shares, which have been reported (via 13F filing form) to have a value of $160 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,673,629
shares
|
$17.1 Million
0.05% of portfolio
|
Q3 2024
Reduced 0.96%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
4,494,851
shares
|
$13.5 Million
18.53% of portfolio
|
Q3 2023
Added 22.76%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2024 Q3 2024 |
4,280,308
shares
|
$12.9 Million
2.12% of portfolio
|
Q4 2023
Added 17.1%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,134,436
shares
|
$12.4 Million
0.38% of portfolio
|
Q3 2024
Added 5.04%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,802,883
shares
|
$11.4 Million
0.68% of portfolio
|
Q3 2024
Added 2.83%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,343,193
shares
|
$10.1 Million
0.0% of portfolio
|
Q2 2024
Added 8.24%
|
|
|
Samlyn Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
3,259,158
shares
|
$9.81 Million
0.27% of portfolio
|
Q3 2024
Reduced 2.73%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
2,822,318
shares
|
$8.5 Million
2.55% of portfolio
|
Q3 2024
Reduced 1.19%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,624,338
shares
|
$7.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.19%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Nov 14, 2024 Q3 2024 |
2,437,689
shares
|
$7.34 Million
0.97% of portfolio
|
Q4 2022
Reduced 0.27%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,744,453
shares
|
$5.25 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.43%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
1,562,500
shares
|
$4.7 Million
4.74% of portfolio
|
Q3 2023
New holding
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
1,368,810
shares
|
$4.12 Million
2.56% of portfolio
|
Q3 2024
Added 20.04%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
1,270,027
shares
|
$3.82 Million
2.63% of portfolio
|
Q3 2023
Added 6.28%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2024 Q3 2024 |
1,191,140
shares
|
$3.59 Million
1.14% of portfolio
|
Q3 2024
Reduced 18.57%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,171,172
shares
|
$3.53 Million
0.0% of portfolio
|
Q3 2024
Added 1.69%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,120,027
shares
|
$3.37 Million
1.93% of portfolio
|
Q2 2024
Reduced 11.81%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,050,420
shares
|
$3.16 Million
0.0% of portfolio
|
Q3 2024
Added 5.04%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,003,124
shares
|
$3.02 Million
0.05% of portfolio
|
Q3 2024
Added 0.24%
|
|
|
Knott David M Jr
Syosset, NY |
Nov 13, 2024 Q3 2024 |
564,549
shares
|
$1.7 Million
1.04% of portfolio
|
Q4 2023
Added 24.35%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
447,317
shares
|
$1.35 Million
0.0% of portfolio
|
Q3 2024
Added 23.61%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
446,152
shares
|
$1.34 Million
0.0% of portfolio
|
Q3 2024
Added 17.39%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
438,845
shares
|
$1.32 Million
0.0% of portfolio
|
Q3 2024
Added 6.68%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
260,719
shares
|
$784,764
0.0% of portfolio
|
Q3 2024
Added 11.91%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
226,232
shares
|
$680,958
0.08% of portfolio
|
Q3 2024
Added 10.24%
|